SecBot SecBot
8-K ·Filed Sep 10, 2026

CTVA

Corteva, Inc.
NEUTRAL
Impact 5/10
Horizonmonths Processed2mo ago SEC0001193125-26-387254
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

The settlement removes a significant litigation overhang for Corteva, resolving statewide PFAS claims in North Carolina with a known, structured payment over 15 years. Monitor for the Effective Date (dismissals becoming final) and any Chemours credit or liquidity issues that could trigger the payment guarantees or Reserve Fund provisions.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$84.49
T+0 close · Sep 10, 2026 · via day close
Latest settled
+8.47%
T+20 · $91.64 · next T+60 in 17d
Vs SPY
+6.34%
α at T+20
Latest observation
−25.19%
T+45 · FF3 residual α
  1. T+0 · Sep 10 $84.49entry
  2. T+1 · 2mo ago −0.70%α −1.55% · $83.90
  3. T+5 · 2mo ago −3.50%α −4.13% · $81.53
  4. T+20 · 6w ago +8.47%α +6.34% · $91.64
  5. T+47 · todayOpen
  6. T+60 · in 17d Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Corteva, Inc. and its subsidiary EIDP, Inc., together with Chemours and DuPont, have reached a comprehensive settlement with the State of North Carolina and multiple local subdivisions to resolve all PFAS-related claims arising from the historic Fayetteville Works site. Under the settlement, the companies will collectively pay $455 million over 15 years, with Corteva's share being approximately $66 million. Additionally, Corteva and DuPont are required to guarantee Chemours' share of the settlement payments and establish a $135 million reserve fund to assure Chemours' remaining obligations under the existing Consent Order.

Key Facts

  • Total settlement amount is $455 million paid over 15 years.
  • Corteva's share is approximately $66 million (14.5% of the total).
  • Corteva and DuPont guarantee Chemours' share of payments (29% and 71% respectively).
  • A $135 million Reserve Fund is to be established for Chemours' remaining Consent Order obligations.
  • The settlement resolves all Released Claims, including the Attorney General North Carolina Action and the Cumberland County action, which will be dismissed with prejudice.
  • Initial payments of $102.5 million ($25M to State, $77.5M to subdivisions) are due within 30 days of the Execution Date (September 9, 2026).

Financial Impact

Corteva's direct cash payment is ~$66 million but it also bears contingent liability for 29% of Chemours' defaulted payments and 29% of a $135M reserve fund.

cash flowcontingent liabilities

Risk Factors

  • Chemours financial or operational distress could trigger Corteva's guarantee of Chemours' settlement payments (29% share of defaulted amounts).
  • Future Credit-Eligible Claims may reduce the State's share of annual payments but could indicate additional litigation activity.
  • Potential for a Multistate Settlement within 5 years that could affect North Carolina's recovery and scope of releases.

Market Snapshot

Exchange
NYSE
Sector
Agricultural Production-Crops
Analyst Consensus
69% bullish (29 analysts)

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-387254
Document: d121501d8k.htm0001193125-26-387254
Document: 0001193125-26-387254-index-headers.html0001193125-26-387254
Document: 0001193125-26-387254-index.html0001193125-26-387254
Document: 0001193125-26-387254.txt0001193125-26-387254

Track record

28 reports on CTVA

Performance horizon

0 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +9.51% at T+60 after the May 5, 2026 report. 2 of 3 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $9.43 to $9.04 Now $9.04 −4.14% ▼ −4.14% −2.22% vs SPY
  2. Nov 12, 20264d ago 8-K Bearish 6/10 Entry $9.19 to $9.43 Now $9.04 +1.63% ▼ −2.61% −2.97% vs SPY
  3. Nov 10, 20266d ago NT 10-Q Neutral 4/10 Entry $12.14 to $9.19 Now $9.04 −25.54% ▼ −24.30% −23.95% vs SPY
  4. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $11.90 to $12.11 Now $9.04 −24.03% ▲ +1.76% −0.60% vs SPY
  5. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $12.04 to $11.90 Now $9.04 −24.92% ▼ −1.16% −1.48% vs SPY
  6. Nov 4, 202612d ago SC 13G/A Neutral 3/10 Entry $12.04 to $11.90 Now $9.04 −24.92% ▼ −1.16% −1.48% vs SPY
  7. Oct 28, 202619d ago Institutional Cluster Mixed 3/10 Entry $11.33 to $11.47 Now $9.04 −20.21% ▲ +1.24% +1.62% vs SPY
  8. Oct 23, 202624d ago Press Release Neutral 2/10 Entry $12.45 to $11.95 Now $9.04 −27.39% ▼ −4.02% −4.73% vs SPY
  9. Oct 13, 20264w ago 8-K Bearish 6/10 Entry $13.36 to $13.40 Now $9.04 +32.34% ▼ −0.30% −1.38% vs SPY
  10. Oct 5, 20266w ago 3 Neutral 2/10 Entry $13.91 to $14.45 Now $9.04 −35.01% ▲ +3.88% +4.12% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens Wed (11h 55m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 10, 2026